Skip to main content

UBS Group AG

Position in FULC — Fulcrum Therapeutics, Inc.

CIK 1610520 ZURICH, V8

Position in FULC

as of Mar 31, 2026 · filed May 5, 2026
Position Value
$2,417,468
+$1,252,913 QoQ
Shares Held
315,185
+206.1% QoQ
Ownership
0.473%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#37
of 168 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority Sole 99.60340752256612.ToString("F0")% Shared 0.ToString("F0")% None 0.39659247743388804.ToString("F0")%

Common Shares in FULC Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

UBS Group AG holds $8,296,969,172 across 554 Biotechnology names. FULC ranks #197 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in FULC

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $2,417,468 315,185
2025-12-31 $1,164,555 102,967
2025-09-30 $2,770,643 301,157
2025-06-30 $930,210 135,205
2025-03-31 $207,128 71,920
2024-12-31 $363,742 77,392
2024-09-30 $287,859 80,633
2024-06-30 $1,181,416 190,551
2024-03-31 $686,929 72,768
2023-12-31 $203,734 30,183
2023-09-30 $49,535 11,157
2023-06-30 $104,804 31,759
2023-03-31 $1,208 424
2022-12-31 $27,583 3,789
2022-03-31 $34,741 1,469
2021-12-31 $14,594 825
2021-09-30 $36,814 1,305
2021-06-30 $9,872 942
2021-03-31 $17,917 1,521
2020-12-31 $3,864 330
2020-09-30 $25,582 3,226
2020-06-30 $79,378 4,340
2020-03-31 $96,869 8,113